The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis
The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis
Laboratory change induced by common bile duct (CBD) stone is in general observed as the
 higher elevation of alkaline phosphatase (ALP) and gamma-glutamyl transpeptideas (ɤ-GT), in
 comparison to those of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
 However, some patients with CBD stone show the marked increased level of aminotransferase,
 which sometimes leads to misdiagnose those as liver disease caused by viral hepatitis,
 ischemia, and drug toxicity. The aim of this study is to investigate the clinicopathologic
 features of patients with CBD stones with the high level of aminotransferase in serum.
Inclusion Criteria:

 1. patients were diagnosed with CBD stone under endoscopic retrograde
 cholangiopancreatography (ERCP)

 2. patients showing above 400 IU/L of aminotransferase when at the first admitted into
 hospital and the control groups is the patients displaying normal AST and ALT.

 Exclusion Criteria:

 -  1. underlying hepatobiliary disease 2. alcoholics 3. cholangitis